Contacto

  • 93 510 68 61
  • info@markelab.com
  • C/ Gibraltar 10-20 Local 3. 08330 Premià de Mar (Barcelona)
CONTACTO

SCHISTOSOMA ICT IgG-IgM

160,00€ (20 test)

SCHISTOSOMA ICT IgG-IgM is a unitary qualitative rapid test based on the immune chromatography technology (lateral flow), allowing the simultaneous detection of both IgG and IgM class anti-Schistosoma antibodies in human sera.

Proveedor

LD Bio

Reference

BILZAbICT20

Tested Applications

ICT

Reactivity

Human

Status

CE Marked

Si quieres saber los precios con descuentos por volumen o bien más características del producto, contáctanos!

SKU: BILZAbICT20 Categoría:

Características de producto

tested_applications
ICT
reactivity
Human
category
ICT
size_1
20 test
size_2
100 test
storage
2 – 8 °C
detection_method
SCHISTOSOMA ICT IgG-IgM is a rapid test based on immunochromatography technology (lateraL flow) used to simultaneously detect both IgG and IgM antibodies
availability
Inmediate
dry_ice
No
note
30 µl serum or Plasma
reserach_area
Schistosoma
background
Schistosomiasis are zoonoses due to the infection by hematophagous trematodes of the Schistosoma genus, that live in the circulatory system. Six species are pathogenic for humans: S. haematobium, S. mansoni, S. japonicum (the 3 main species), S. mekongi, S. intercalatum and S. guineensis. They are responsible of three forms of infection: intestinal, urogenital or arteriovenous.